Detalhe da pesquisa
1.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
Rheumatology (Oxford)
; 62(5): 1877-1886, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173318
2.
Co prescription of anti-acid therapy reduces the bioavailability of mycophenolate mofetil in systemic sclerosis patients: A crossover trial.
Semin Arthritis Rheum
; 63: 152270, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820508
3.
Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial.
Rheumatology (Oxford)
; 49(12): 2420-8, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20837499
4.
Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.
Clin Rheumatol
; 38(9): 2399-2402, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076945
5.
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
Arthritis Res Ther
; 18(1): 123, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27255492